Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nested-block scalable framework for efficient and equitable urban infrastructure management.

Communications engineering·2026
Same author

TREM2 mediates macrophage suppression of NLRP3 inflammasome pathway to promote non-small cell lung cancer progression.

Molecular and cellular biochemistry·2026
Same author

Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR.

Alimentary pharmacology & therapeutics·2026
Same author

Pattern-enhanced Resonant Soft X-ray Scattering for Operando monitoring of electrochemical solid-liquid interfaces.

Nature communications·2026
Same author

Single-cell multi-omics reveals DUSP9 as a key regulator of cancer stemness and a potential therapeutic target in hepatocellular carcinoma.

Journal of translational medicine·2026
Same author

A cis-regulatory element of the PHYTOCHROME A gene confers the submergence escape capacity for amphibious plants.

Nature communications·2025

Related Experiment Video

Updated: Aug 15, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma.

Qinghui Zhu1, Shaoping Shen1, Chuanwei Yang1

  • 1Department of Neurosurgical Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Frontiers in Neurology
|January 2, 2023
PubMed
Summary

This study identifies seven key messenger RNAs (mRNAs) to predict oligodendroglioma patient survival, aiding in personalized treatment strategies. The developed prognostic model shows high accuracy in predicting patient outcomes.

Keywords:
1p/19q codeletionWHO CNS 5mRNA-sequenceoligodendrogliomaprognostic model

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Related Experiment Videos

Last Updated: Aug 15, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

Area of Science:

  • Neuro-oncology
  • Genomics
  • Molecular Biology

Background:

  • Oligodendroglioma diagnosis now relies on specific genetic markers: 1p/19q codeletion and IDH mutation.
  • Traditional prognostic factors may be less relevant for oligodendroglioma under new WHO CNS 5 criteria.
  • Identifying novel prognostic indicators is crucial for accurate patient outcome prediction.

Purpose of the Study:

  • To identify novel prognostic indicators for oligodendroglioma.
  • To develop and validate a prognostic model using mRNA expression data.
  • To guide personalized treatment for oligodendroglioma patients.

Main Methods:

  • Analysis of 165 oligodendroglioma mRNA-sequence datasets from the Chinese Glioma Genome Atlas (CGGA).
  • Utilized Least Absolute Shrinkage and Selection Operator (LASSO) regression to identify differentially expressed mRNAs (DE mRNAs) between long- and short-survival groups.
  • Developed a prognostic model incorporating risk score, age, and primary-or-recurrent status (PRS), validated using univariate and multivariate analyses and qRT-PCR.

Main Results:

  • Identified 88 DE mRNAs between survival groups; selected seven key RNAs for the prognostic model.
  • The final model included risk level, age, and PRS, demonstrating statistical significance for survival.
  • Achieved optimal predictive accuracy (C-index = 0.912) with good agreement in both training and validation cohorts.

Conclusions:

  • A novel prognostic model for oligodendroglioma based on mRNA expression data has been established.
  • The model exhibits high predictive accuracy and has been successfully validated.
  • The identified seven mRNAs can aid in predicting prognosis and informing personalized treatment decisions for oligodendroglioma.